Show simple item record

dc.contributor.authorAlvergne, A
dc.contributor.authorKountourides, G
dc.contributor.authorArgentieri, MA
dc.contributor.authorAgyen, L
dc.contributor.authorRogers, N
dc.contributor.authorKnight, D
dc.contributor.authorSharp, GC
dc.contributor.authorMaybin, JA
dc.contributor.authorOlszewska, Z
dc.date.accessioned2023-11-01T09:49:47Z
dc.date.issued2023-03-21
dc.date.updated2023-10-31T16:59:39Z
dc.description.abstractThere has been increasing public concern that COVID-19 vaccination causes menstrual disturbance regarding the relative effect of vaccination compared to SARS-CoV-2 infection. Our objectives were to test potential risk factors for reporting menstrual cycle changes following COVID-19 vaccination and to compare menstrual parameters following COVID-19 vaccination and COVID-19 disease. We performed a secondary analysis of a retrospective online survey conducted in the UK in March 2021. In pre-menopausal vaccinated participants (n = 4,989), 18% reported menstrual cycle changes after their first COVID-19 vaccine injection. The prevalence of reporting any menstrual changes was higher for women who smoke, have a history of COVID-19 disease, or are not using estradiol-containing contraceptives. In a second sample including both vaccinated and unvaccinated participants (n = 12,579), COVID-19 vaccination alone was not associated with abnormal menstrual cycle parameters, while a history of COVID-19 disease was associated with an increased risk of reporting heavier bleeding, "missed" periods, and inter-menstrual bleeding.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipRoyal Society of Edinburghen_GB
dc.description.sponsorshipMedical Research Centeren_GB
dc.description.sponsorshipMedical Research Centeren_GB
dc.description.sponsorshipBritish Academyen_GB
dc.description.sponsorshipEconomic and Social Research Council (ESRC)en_GB
dc.format.extent106401-
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 26, No. 4, article 106401en_GB
dc.identifier.doihttps://doi.org/10.1016/j.isci.2023.106401
dc.identifier.grantnumber209589/Z/17/Zen_GB
dc.identifier.grantnumberIS3-R3.11 21/22en_GB
dc.identifier.grantnumber1077en_GB
dc.identifier.grantnumberG1002033en_GB
dc.identifier.grantnumberMR/N022556/1en_GB
dc.identifier.grantnumberMD19\190016en_GB
dc.identifier.grantnumberES/P000649/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/134377
dc.identifierORCID: 0000-0003-2906-4035 (Sharp, Gemma C)
dc.identifierScopusID: 56898577600 (Sharp, Gemma C)
dc.language.isoenen_GB
dc.publisherCell Pressen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/36987520en_GB
dc.rights© 2023 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en_GB
dc.subjectHealth sciencesen_GB
dc.subjectImmunologyen_GB
dc.subjectPublic healthen_GB
dc.subjectWomen's healthen_GB
dc.titleA retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease.en_GB
dc.typeArticleen_GB
dc.date.available2023-11-01T09:49:47Z
dc.identifier.issn2589-0042
exeter.article-number106401
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available from Cell Press via the DOI in this record. en_GB
dc.identifier.journaliScienceen_GB
dc.relation.ispartofiScience, 26(4)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-03-09
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-03-21
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-11-01T09:44:31Z
refterms.versionFCDVoR
refterms.dateFOA2023-11-01T09:49:54Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-03-21


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Except where otherwise noted, this item's licence is described as © 2023 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)